- Novo Nordisk’s Wegovy gets UK approval for use to lower heart risks Reuters.com
- Weight-loss drug given green light to tackle heart problems BBC.com
- MHRA approves GLP –1 receptor agonist semaglutide to reduce risk of serious heart problems in obese or overweight adults GOV.UK
- Wegovy wins…
[ad_2]
Source link
